Leptin and ghrelin levels in patients with obstructive sleep apnoea: Effect of CPAP treatment

European Respiratory Journal

Volumn 22, Issue 2, 2003, Pages 251-257

  Harsch, Igor A ^a   Konturek, P C ^a   Koebnick, C ^b   Kuehnlein, P P ^a   Fuchs, F S ^a   Pour Schahin, S ^a   Wiest, G H ^a   Hahn, E G ^a   Lohmann, T ^a   Ficker, J H ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Continuous positive airways pressure; Ghrelin; Leptin; Obesity; Obstructive sleep apnoea syndrome; Sleep

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GHRELIN; INSULIN; LEPTIN; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET RESTRICTION; ELECTROENCEPHALOGRAPHY; ELECTROOCULOGRAPHY; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MALE; OBESITY; PLETHYSMOGRAPH; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE OXIMETRY; SLEEP APNEA SYNDROME; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; BLOOD GAS ANALYSIS; BODY MASS INDEX; CASE-CONTROL STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALE; MIDDLE AGED; OBESITY; PEPTIDE HORMONES; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE;

EID: 10744228002     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00010103     Document Type: Article

References (44)

1. Strollo PJ, Rogers RM. Obstructive sleep apnea. N Engl J Med 1996; 334: 99-104.
2. Smith R, Ronald J, Delaive K, Walld R, Manfreda J, Kryger MH. What are obstructive sleep apnea patients being treated for prior to this diagnosis? Chest 2002; 121: 164-172.
3. Phillips BG, Hisel TM, Kato M, et al. Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens 1999; 17: 1297-1300.
4. Caro JF, Kolaczynski JW, Nyce MR, et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348: 159-161.
5. O'Donnell CP, Tankersley CG, Polotsky VP, Schwartz AR, Smith PL. Leptin, obesity, and respiratory function. Respir Physiol 2000; 119: 163-170.
6. Tankersley CG, O'Donnell C, Daood MJ. Leptin attenuates respiratory complications associated with the obese phenotype. J Appl Physiol 1998; 85: 2261-2269.
7. Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000; 118: 569-571.
8. Chin K, Shinizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999; 100: 706-712.
9. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
10. Saad MF, Riad-Gabriel MG, Khan A, et al. Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity. J Clin Endocrinol Metab 1998; 83: 453-459.
11. Sinha MK, Ohannesian JP, Heimann ML, et al. Nocturnal rise of leptin in obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 1996; 97: 1344-1347.
12. Sinha MK, Sturis J, Ohannesian J, el al. Ultradian oscillations of leptin secretions in humans. Biochem Biophys Res Commun 1996; 228: 733-738.
13. Mantzoros CS, Ozata M, Negrao, et al. Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: Evidence for possible partial TSH regulation by leptin in humans. J Clin Endocrinol Metab 2001; 86: 3284-3291.
14. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
15. Shintani M, Ogawa Y, Ebihara K, et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001; 50: 227-232.
16. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2002; 86: 5992-5997.
17. Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heimann ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707-709.
18. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsihgnji DJ. Distribution of mRNA encoding the growth hormone receptor in brain and peripheral tissues. Brain Res Mol Brain Res 1997; 48: 23-29.
19. Papotti M, Ghe C, Cassoni P, et al. Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab 2000; 85: 3803-3807.
20. Weikel JC, Wichniak A, Ising M, et al. Ghrelin promotes slow wave sleep in young normal men. Am J Physiol Endocrinol Metab 2002; 284: E407-E415.
21. Ficker JH, Wiest GH, Wilpert J, Fuchs FS, Hahn EG. Evaluation of a portable recording device (Somnocheck) for use in patients with suspected obstructive sleep apnoea. Respiration 2001; 68: 307-312.
22. Rosenbaum M, Nicholson M, Hirsch J, et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996; 81: 3424-3427.
23. Miell JP, Englaro P, Blum WF. Dexamethasone induces an acute and sustained rise in circulating leptin levels in normal human subjects. Horm Metab Res 1996; 28: 704-707.
24. Larsson H, Ahren B. Short-term dexamethasone treatment increases plasma leptin independently of change in insulin sensitivity in healthy women. J Clin Endocrinol Metab 1996; 81: 4428-4432.
25. Papaspyrou-Rao S, Schneider SH, Peteraen RN, Fried SK. Dexamethasone increases leptin expression in humans in vitro. J Clin Endocrinol Metab 1997; 82: 2542-2547.
26. Rosenbaum M, Nicholson M, Hirsch J, Heymsfield SB, Gallager D, Chu F. Suppressive effects of androgens on plasma leptin levels while estrogen-progesteron induce higher levels. J Clin Endocrinol Metab 1996; 81: 3424-3427.
27. Donahoo, WT, Jensen TR, Yost TJ, Eckel RH. Isoproterenol and beta 3-receptor agonists reduce leptin mRNA expression and circulating levels. J Clin Endocrinol Metab 1997; 82: 4319-4343.
28. Kolaczynski JW, Ohannesian JW, Considine RV, Marco CC, Caro JF. Responses of leptin to short-term fasting and refeeding in humans. Diabetes 1996; 45: 1511-1515.
29. Ficker JH, Wiest GH, Lehnert G, Hahn EG. Evaluation of an auto-CPAP device for treatment of obstructive sleep apnoea. Thorax 1998; 53: 643-648.
30. Gould GA, Whyte GB, Airlie MAA, Catterall JR, Shapiro CM, Douglas NJ. The sleep hypopnoea syndrome. Am Rev Respir Dis 1988; 137: 895-898.
31. Rechtschaffen A, Kahles A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles, Public Health Service, US Government Printing, 1968.
32. Bonnet M, Charley D, Carskadon MA. EEG arousals: scoring rules and examples. Sleep 1992; 15: 174-184.
33. Garrow JS, Webster J. Quetelet's index (W/H2) as a measure of fatness. Int J Obesity 1985; 9: 147-153.
34. Johns MW. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 1991; 14: 540-545.
35. O'Donnell CP, Schaub CD, Haines AS, et al. Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med 1999; 159: 1477-1484.
36. Saad MF, Bernaba B, Hwu C-M, et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 2002; 87: 3997-4000.
37. Grunstein RR. Metabolic aspects of sleep apnea. Sleep 1996; 19: S218-S220.
38. Ip MS, Lam B, Ng MMT, Lam WK, Tsang KWT, Lam KSL. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2003; 165: 670-676.
39. Luboshitzky R, Aviv A, Hefetz A, et al. Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. J Clin Endocrinol Metab 2002; 87: 3394-3398.
40. Bjorntorp P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 1997; 13: 795-803.
41. Snitker P, Pratley RE, Nicholson M, Tartarini PA, Ravussin E. Relationship between muscle sympathetic nerve activity and plasma leptin concentration. Obes Res 1997; 5: 338-340.
42. Phillips BG, Kato M, Narkiewicz K, et al. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000; 279: 234-237.
43. Manzella D, Prillo M, Razzino T, et al. Soluble leptin receptor and insulin resistance as determinant of sleep apnea. Int J Obesity 2002; 26: 370-375.
44. Schäfer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 2002; 122: 829-839.